On Monday, MAIA Biotechnology Inc (AMEX: MAIA) was 1.18% up from the session before settling in for the closing price of $1.7. A 52-week range for MAIA has been $1.40 – $3.74.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -11.40%. When this article was written, the company’s average yearly earnings per share was at 51.52%. With a float of $21.93 million, this company’s outstanding shares have now reached $29.59 million.
The extent of productivity of a business whose workforce counts for 13 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
MAIA Biotechnology Inc (MAIA) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward MAIA Biotechnology Inc stocks. The insider ownership of MAIA Biotechnology Inc is 27.63%, while institutional ownership is 4.09%. The most recent insider transaction that took place on Jun 03 ’25, was worth 50,000. In this transaction Director of this company bought 33,333 shares at a rate of $1.50, taking the stock ownership to the 1,305,059 shares. Before that another transaction happened on May 08 ’25, when Company’s Director bought 20,000 for $1.50, making the entire transaction worth $30,000. This insider now owns 588,218 shares in total.
MAIA Biotechnology Inc (MAIA) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 51.52% per share during the next fiscal year.
MAIA Biotechnology Inc (AMEX: MAIA) Trading Performance Indicators
You can see what MAIA Biotechnology Inc (MAIA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.35.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.81, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -0.69 in one year’s time.
Technical Analysis of MAIA Biotechnology Inc (MAIA)
The latest stats from [MAIA Biotechnology Inc, MAIA] show that its last 5-days average volume of 0.75 million was superior to 0.34 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 26.92%.
During the past 100 days, MAIA Biotechnology Inc’s (MAIA) raw stochastic average was set at 23.88%, which indicates a significant increase from 15.69% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0993 in the past 14 days, which was lower than the 0.1408 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.7792, while its 200-day Moving Average is $1.9820. Now, the first resistance to watch is $1.8333. This is followed by the second major resistance level at $1.9467. The third major resistance level sits at $2.0083. If the price goes on to break the first support level at $1.6583, it is likely to go to the next support level at $1.5967. The third support level lies at $1.4833 if the price breaches the second support level.
MAIA Biotechnology Inc (AMEX: MAIA) Key Stats
There are 30,307K outstanding shares of the company, which has a market capitalization of 52.13 million. As of now, sales total 0 K while income totals -23,250 K. Its latest quarter income was 0 K while its last quarter net income were -4,520 K.
